NCT04975802

Effect of Coffeeberry on Mood and Cognitive Performance

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 72 (actual)
• Sponsor: PepsiCo Global R&D · Industry
• Sex: All
• Age: 18 Years – 49 Years
• Healthy volunteers: Accepted

Summary

The primary aim of this randomised, double-blind, placebo-controlled, cross-over study is to assess the short-term cognitive effects of two beverages containing 100 and 300 mg coffeeberry extract (obtained from the fruit of the coffee plant (Coffea arabica) compared to a placebo beverage. The trial will utilise the COMPASS cognitive assessment system and cognitive demand battery (CDB) and mood visual analogue scales (VAS) with assessments taking place at baseline, 60- and 120-minutes post treatment, on four separate testing days separated by 7 days. A treatment containing 75 mg caffeine will be used as a positive control to document participants' responsiveness to an established psychostimulant.

Conditions

• Mental Fatigue
• Alertness
• Mood
• Cognition

Interventions

Type	Name	Description
OTHER	Placebo	10 oz (296 ml) cherry flavored still beverage
DIETARY_SUPPLEMENT	Coffeeberry	10 oz (296 ml) cherry flavored still beverage
DIETARY_SUPPLEMENT	Caffeine	10 oz (296 ml) cherry flavored still beverage

Timeline

• Start date: 2021-07-05
• Primary completion: 2022-02-04
• Completion: 2022-02-04
• First posted: 2021-07-23
• Last updated: 2022-03-24

Locations

1 site across 1 country: United Kingdom